Alzamend Neuro, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Alzamend Neuro, Inc. reported Cash And Cash Equivalents At Carrying Value of $3.95 million for the year ending 2025.

  • Alzamend Neuro, Inc. showed an increase of +950.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Alzamend Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on July 22, 2025.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Alzamend Neuro, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 9,167.8%.
  • Historical annual values: Fiscal year 2025: $3.95 million | Fiscal year 2024: $376.0 thousand | Fiscal year 2023: $5.14 million | Fiscal year 2022: $14.06 million | Fiscal year 2021: $1.93 million | Fiscal year 2020: $90.3 thousand | Fiscal year 2019: $42.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: